Trial intelligence / Profile preview

EASY-RESCUE: Abciximab in Rescue PCI

NCT00440895Phase 4Completed

Start
Feb 2007
Primary completion
Oct 2012
Modality
Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of abciximab in acute myocardial infarction (AMI) (3 arms). Primary endpoints: TIMI score at 6 months and Myocardial Blush Grade at 6 months. Started Feb 2007; status: completed.

02

Drugs

abciximab
03

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT00440895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00440895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call